Cargando…
Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update
BACKGROUND: Although significant improvement in efficacy measured by a sustained virological response, the high acquisition costs of direct-acting antivirals limit the access for patients and influence the costs of healthcare resource utilisation in hepatitis C. It is important to have the latest es...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647266/ https://www.ncbi.nlm.nih.gov/pubmed/31337339 http://dx.doi.org/10.1186/s12879-019-4284-9 |